Loading...
XSHE
000766
Market cap2.20bUSD
Jul 10, Last price  
16.50CNY
1D
6.66%
1Q
-21.62%
Jan 2017
-6.04%
Name

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd

Chart & Performance

D1W1MN
XSHE:000766 chart
P/E
465.12
P/S
13.63
EPS
0.04
Div Yield, %
—
Shrs. gr., 5y
-2.37%
Rev. gr., 5y
1.02%
Revenues
1.17b
-11.54%
141,337,377151,588,510159,856,088168,163,754169,587,054179,139,146127,647,610147,781,836208,414,736197,558,720850,083,3701,521,410,2942,094,549,3741,977,206,4331,111,802,3961,515,482,4721,470,748,7741,473,345,3001,322,557,7231,169,957,653
Net income
34m
-39.25%
-8,566,00018,829,20017,180,03229,790,95512,018,50611,241,4263,856,6394,092,1395,165,6506,863,116213,461,478257,879,259330,858,119-2,041,890,388-359,496,10235,273,25330,151,34843,933,71056,437,32634,286,477
CFO
105m
-35.45%
-18,016,7789,951,67610,260,87779,941,57729,054,265-7,932,276-6,494,214102,962,80134,317,920-160,949,74690,629,09926,434,194170,722,97574,861,07880,705,132138,329,704198,163,857112,779,071162,746,489105,054,454
Dividend
May 25, 20010.7 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. is a Chinese pharmaceutical firm actively involved in the full spectrum of drug development, from research and development to manufacturing and sales. Its therapeutic focus primarily encompasses key areas such as rheumatism, digestive health, oncology, and gynecology. The company boasts a comprehensive and diverse product portfolio. This includes a wide array of traditional Chinese medicines (TCMs), addressing conditions like gynecological issues, rheumatic and bone pain, urological disorders, detoxification needs, cardiovascular and cerebral health, digestive and respiratory ailments, diabetes, and pediatric concerns. Beyond TCMs, it also develops and markets anti-tumor drugs, both prescription and over-the-counter (OTC) medications, and conventional Western pharmaceuticals. These products are available in multiple dosage forms, including capsules, tablets, injections, and liquid preparations. Established in 1990, the company is headquartered in Tonghua, China.
URL
http://www.thjm.cn/
IPO date
Apr 30, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT